Familial Cancer

, Volume 12, Issue 2, pp 285–293 | Cite as

Do lifestyle factors influence colorectal cancer risk in Lynch syndrome?

  • Fränzel J. B. van Duijnhoven
  • Akke Botma
  • Renate Winkels
  • Fokko M. Nagengast
  • Hans F. A. Vasen
  • Ellen Kampman
Original Article

Abstract

Lynch syndrome (LS) is one of the inherited colorectal cancer (CRC) syndromes and is due to germline mutations in one of the mismatch repair (MMR) genes. Within LS affected-families the expression of the syndrome varies, which suggests that other factors, such as lifestyle factors, have an influence on the LS phenotype. This review gives an overview of studies that assessed the role of lifestyle factors in the development of CRC in LS. Several published studies investigated smoking habits or body fatness (BMI) in relation to colorectal tumours. Those studies fairly consistently suggest that smoking and a high BMI markedly increase the risk of CRC in persons with LS. Other lifestyle factors, such as physical activity, alcohol or diet have not or only scarcely been studied. Lifestyle factors may indeed affect CRC risk in LS. However, more prospective studies with only confirmed MMR gene mutation carriers should be done to further elucidate the role of all lifestyle factors in CRC and in other types of cancer in persons with LS. Information on the role of lifestyle factors in the development of LS-associated cancers may help in establishing lifestyle and dietary recommendations with the ultimate goal of decreasing cancer risk in persons with LS.

Keywords

Lifestyle factors Colorectal cancer Lynch syndrome 

References

  1. 1.
    Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, Mecklin JP, de la Chapelle A (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338(21):1481–1487. doi:10.1056/nejm199805213382101 PubMedCrossRefGoogle Scholar
  2. 2.
    Cunningham JM, Kim CY, Christensen ER, Tester DJ, Parc Y, Burgart LJ, Halling KC, McDonnell SK, Schaid DJ, Walsh Vockley C, Kubly V, Nelson H, Michels VV, Thibodeau SN (2001) The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 69(4):780–790. doi:10.1086/323658 PubMedCrossRefGoogle Scholar
  3. 3.
    Hampel H, Frankel WL, Martin E, Arnold M, Khanduja K, Kuebler P, Nakagawa H, Sotamaa K, Prior TW, Westman J, Panescu J, Fix D, Lockman J, Comeras I, de la Chapelle A (2005) Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352(18):1851–1860. doi:10.1056/NEJMoa043146 PubMedCrossRefGoogle Scholar
  4. 4.
    Lamberti C, Mangold E, Pagenstecher C, Jungck M, Schwering D, Bollmann M, Vogel J, Kindermann D, Nikorowitsch R, Friedrichs N, Schneider B, Houshdaran F, Schmidt-Wolf IG, Friedl W, Propping P, Sauerbruch T, Buttner R, Mathiak M (2006) Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany. Digestion 74(1):58–67. doi:10.1159/000096868 PubMedCrossRefGoogle Scholar
  5. 5.
    Pinol V, Castells A, Andreu M, Castellvi-Bel S, Alenda C, Llor X, Xicola RM, Rodriguez-Moranta F, Paya A, Jover R, Bessa X, Gastrointestinal Oncology Group of the Spanish Gastroenterological A (2005) Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293(16):1986–1994. doi:10.1001/jama.293.16.1986 PubMedCrossRefGoogle Scholar
  6. 6.
    Salovaara R, Loukola A, Kristo P, Kaariainen H, Ahtola H, Eskelinen M, Harkonen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Jarvinen H, Mecklin JP, Aaltonen LA, de la Chapelle A (2000) Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 18(11):2193–2200PubMedGoogle Scholar
  7. 7.
    Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, Nichols M, Gruenthal K, Leppert MF, Slattery ML (2001) The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121(4):830–838PubMedCrossRefGoogle Scholar
  8. 8.
    Lin KM, Shashidharan M, Thorson AG, Ternent CA, Blatchford GJ, Christensen MA, Watson P, Lemon SJ, Franklin B, Karr B, Lynch J, Lynch HT (1998) Cumulative incidence of colorectal and extracolonic cancers in MLH1 and MSH2 mutation carriers of hereditary nonpolyposis colorectal cancer. Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2(1):67–71CrossRefGoogle Scholar
  9. 9.
    Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, Ruschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HF, Hawk ET, Barrett JC, Freedman AN, Srivastava S (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96(4):261–268PubMedCrossRefGoogle Scholar
  10. 10.
    Warthin AS (1913) Heredity with reference to carcinoma: as shown by the study of the cases examined in the pathological laboratory of the University of Michigan. Archives of internal medicine XII 5:546–555CrossRefGoogle Scholar
  11. 11.
    Douglas JA, Gruber SB, Meister KA, Bonner J, Watson P, Krush AJ, Lynch HT (2005) History and molecular genetics of Lynch syndrome in family G: a century later. JAMA 294(17):2195–2202. doi:10.1001/jama.294.17.2195 PubMedCrossRefGoogle Scholar
  12. 12.
    Lynch HT, Krush AJ (1971) Cancer family “G” revisited: 1895–1970. Cancer 27(6):1505–1511PubMedCrossRefGoogle Scholar
  13. 13.
    Vasen HF, Offerhaus GJ, den Hartog Jager FC, Menko FH, Nagengast FM, Griffioen G, van Hogezand RB, Heintz AP (1990) The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer 46(1):31–34PubMedCrossRefGoogle Scholar
  14. 14.
    Barrow E, Alduaij W, Robinson L, Shenton A, Clancy T, Lalloo F, Hill J, Evans DG (2008) Colorectal cancer in HNPCC: cumulative lifetime incidence, survival and tumour distribution. A report of 121 families with proven mutations. Clin Genet 74(3):233–242. doi:10.1111/j.1399-0004.2008.01035 PubMedCrossRefGoogle Scholar
  15. 15.
    Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, Liu B, Kinzler KW, Vogelstein B (1997) Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 6(1):105–110PubMedCrossRefGoogle Scholar
  16. 16.
    Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, de la Chapelle A (2005) Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 129(2):415–421. doi:10.1016/j.gastro.2005.05.011 PubMedGoogle Scholar
  17. 17.
    Jenkins MA, Baglietto L, Dowty JG, Van Vliet CM, Smith L, Mead LJ, Macrae FA, St John DJ, Jass JR, Giles GG, Hopper JL, Southey MC (2006) Cancer risks for mismatch repair gene mutation carriers: a population-based early onset case-family study. Clin Gastroenterol Hepatol 4(4):489–498. doi:10.1016/j.cgh.2006.01.002 PubMedCrossRefGoogle Scholar
  18. 18.
    Quehenberger F, Vasen HF, van Houwelingen HC (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet 42(6):491–496. doi:10.1136/jmg.2004.024299 PubMedCrossRefGoogle Scholar
  19. 19.
    Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, Lindblom A, Lagerstedt K, Thibodeau SN, Lindor NM, Young J, Winship I, Dowty JG, White DM, Hopper JL, Baglietto L, Jenkins MA, de la Chapelle A (2008) The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135(2):419–428. doi:10.1053/j.gastro.2008.04.026 PubMedCrossRefGoogle Scholar
  20. 20.
    Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, Wang F, Bandipalliam P, Syngal S, Gruber SB (2009) Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137(5):1621–1627. doi:10.1053/j.gastro.2009.07.039 PubMedCrossRefGoogle Scholar
  21. 21.
    Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2009_pops09/, based on November 2011 SEER data submission, posted to the SEER web site, April 2012
  22. 22.
    Abdel-Rahman WM, Mecklin JP, Peltomaki P (2006) The genetics of HNPCC: application to diagnosis and screening. Crit Rev Oncol Hematol 58(3):208–220. doi:10.1016/j.critrevonc.2005.11.001 PubMedCrossRefGoogle Scholar
  23. 23.
    Ligtenberg MJ, Kuiper RP, Chan TL, Goossens M, Hebeda KM, Voorendt M, Lee TY, Bodmer D, Hoenselaar E, Hendriks-Cornelissen SJ, Tsui WY, Kong CK, Brunner HG, van Kessel AG, Yuen ST, van Krieken JH, Leung SY, Hoogerbrugge N (2009) Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 41(1):112–117. doi:10.1038/ng.283 PubMedCrossRefGoogle Scholar
  24. 24.
    Botteri E, Iodice S, Bagnardi V, Raimondi S, Lowenfels AB, Maisonneuve P (2008) Smoking and colorectal cancer: a meta-analysis. JAMA 300(23):2765–2778PubMedCrossRefGoogle Scholar
  25. 25.
    Liang PS, Chen TY, Giovannucci E (2009) Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer 124(10):2406–2415. doi:10.1002/ijc.24191 PubMedCrossRefGoogle Scholar
  26. 26.
    Gram IT, Braaten T, Lund E, Le Marchand L, Weiderpass E (2009) Cigarette smoking and risk of colorectal cancer among Norwegian women. Cancer Causes Control 20(6):895–903. doi:10.1007/s10552-009-9327-x PubMedCrossRefGoogle Scholar
  27. 27.
    Hannan LM, Jacobs EJ, Thun MJ (2009) The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomarkers Prev 18(12):3362–3367. doi:10.1158/1055-9965.epi-09-0661 PubMedCrossRefGoogle Scholar
  28. 28.
    Leufkens AM, Van Duijnhoven FJ, Siersema PD, Boshuizen HC, Vrieling A, Agudo A, Gram IT, Weiderpass E, Dahm C, Overvad K, Tjonneland A, Olsen A, Boutron-Ruault MC, Clavel-Chapelon F, Morois S, Palli D, Grioni S, Tumino R, Sacerdote C, Mattiello A, Herman S, Kaaks R, Steffen A, Boeing H, Trichopoulou A, Lagiou P, Trichopoulos D, Peeters PH, van Gils CH, van Kranen H, Lund E, Dumeaux V, Engeset D, Rodriguez L, Sanchez MJ, Chirlaque MD, Barricarte A, Manjer J, Almquist M, van Guelpen B, Hallmans G, Khaw KT, Wareham N, Tsilidis KK, Straif K, Leon-Roux M, Vineis P, Norat T, Riboli E, Bueno-de-Mesquita HB (2011) Cigarette smoking and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study. Clin Gastroenterol Hepatol 9(2):137–144. doi:10.1016/j.cgh.2010.10.012 PubMedCrossRefGoogle Scholar
  29. 29.
    Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ (2010) Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 102(14):1012–1022. doi:10.1093/jnci/djq201 PubMedCrossRefGoogle Scholar
  30. 30.
    Nordenvall C, Nilsson PJ, Ye W, Nyren O (2011) Smoking, snus use and risk of right- and left-sided colon, rectal and anal cancer: a 37-year follow-up study. Int J Cancer 128(1):157–165. doi:10.1002/ijc.25305 PubMedCrossRefGoogle Scholar
  31. 31.
    World Cancer Research Fund/American Institute for Cancer Research (2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective. AICR, Washington DCGoogle Scholar
  32. 32.
    World Cancer Research Fund/American Institute for Cancer Research (2011) Continuous Update Project Report: The associations between food, nutrition and physical activity and the risk of colorectal cancerGoogle Scholar
  33. 33.
    Dai Z, Xu YC, Niu L (2007) Obesity and colorectal cancer risk: a meta-analysis of cohort studies. World journal of gastroenterology : WJG 13(31):4199–4206PubMedGoogle Scholar
  34. 34.
    Larsson SC, Wolk A (2007) Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 86(3):556–565PubMedGoogle Scholar
  35. 35.
    Moghaddam AA, Woodward M, Huxley R (2007) Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 16(12):2533–2547. doi:10.1158/1055-9965.epi-07-0708 PubMedCrossRefGoogle Scholar
  36. 36.
    Ning Y, Wang L, Giovannucci EL (2010) A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 11(1):19–30. doi:10.1111/j.1467-789X.2009.00613 PubMedCrossRefGoogle Scholar
  37. 37.
    Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 371(9612):569–578PubMedCrossRefGoogle Scholar
  38. 38.
    Aune D, Chan DS, Lau R, Vieira R, Greenwood DC, Kampman E, Norat T (2011) Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies. BMJ 343:d6617PubMedCrossRefGoogle Scholar
  39. 39.
    Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, Kampman E, Norat T (2011) Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS ONE 6(6):e20456. doi:10.1371/journal.pone.0020456 PubMedCrossRefGoogle Scholar
  40. 40.
    Miller PE, Lesko SM, Muscat JE, Lazarus P, Hartman TJ (2010) Dietary patterns and colorectal adenoma and cancer risk: a review of the epidemiological evidence. Nutr Cancer 62(4):413–424. doi:10.1080/01635580903407114 PubMedCrossRefGoogle Scholar
  41. 41.
    Randi G, Edefonti V, Ferraroni M, La Vecchia C, Decarli A (2010) Dietary patterns and the risk of colorectal cancer and adenomas. Nutr Rev 68(7):389–408. doi:10.1111/j.1753-4887.2010.00299.x PubMedCrossRefGoogle Scholar
  42. 42.
    Diergaarde B, Braam H, Vasen HF, Nagengast FM, van Muijen GN, Kok FJ, Kampman E (2007) Environmental factors and colorectal tumor risk in individuals with hereditary nonpolyposis colorectal cancer. Clin Gastroenterol Hepatol 5(6):736–742. doi:10.1016/j.cgh.2007.02.019 PubMedCrossRefGoogle Scholar
  43. 43.
    Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, LeMarchand L, Lindor NM, Campbell PT, Newcomb PA, Potter JD, Baron JA, Frazier ML, Amos CI (2010) Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clinical cancer research : an official journal of the American Association for. Cancer Res 16(4):1331–1339. doi:10.1158/1078-0432.ccr-09-1877 Google Scholar
  44. 44.
    Watson P, Ashwathnarayan R, Lynch HT, Roy HK (2004) Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med 164(22):2429–2431. doi:10.1001/archinte.164.22.2429 PubMedCrossRefGoogle Scholar
  45. 45.
    Brand RM, Jones DD, Lynch HT, Brand RE, Watson P, Ashwathnayaran R, Roy HK (2006) Risk of colon cancer in hereditary non-polyposis colorectal cancer patients as predicted by fuzzy modeling: influence of smoking. World journal of gastroenterology : WJG 12(28):4485–4491PubMedGoogle Scholar
  46. 46.
    Winkels RM, Botma A, Van Duijnhoven FJ, Nagengast FM, Kleibeuker JH, Vasen HF, Kampman E (2012) Smoking increases the risk for colorectal adenomas in patients with Lynch syndrome. Gastroenterology 142(2):241–247. doi:10.1053/j.gastro.2011.10.033 PubMedCrossRefGoogle Scholar
  47. 47.
    Campbell PT, Jacobs ET, Ulrich CM, Figueiredo JC, Poynter JN, McLaughlin JR, Haile RW, Jacobs EJ, Newcomb PA, Potter JD, Le Marchand L, Green RC, Parfrey P, Younghusband HB, Cotterchio M, Gallinger S, Jenkins MA, Hopper JL, Baron JA, Thibodeau SN, Lindor NM, Limburg PJ, Martinez ME, Colon Cancer Family Registry (2010) Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 102(6):391–400. doi:10.1093/jnci/djq011 PubMedCrossRefGoogle Scholar
  48. 48.
    Win AK, Dowty JG, English DR, Campbell PT, Young JP, Winship I, Macrae FA, Lipton L, Parry S, Young GP, Buchanan DD, Martinez ME, Jacobs ET, Ahnen DJ, Haile RW, Casey G, Baron JA, Lindor NM, Thibodeau SN, Newcomb PA, Potter JD, Le Marchand L, Gallinger S, Hopper JL, Jenkins MA (2011) Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer 105(1):162–169. doi:10.1038/bjc.2011.172 PubMedCrossRefGoogle Scholar
  49. 49.
    Botma A, Nagengast FM, Braem MG, Hendriks JC, Kleibeuker JH, Vasen HF, Kampman E (2010) Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol 28(28):4346–4353. doi:10.1200/jco.2010.28.0453 PubMedCrossRefGoogle Scholar
  50. 50.
    Voskuil DW, Kampman E, Grubben MJ, Kok FJ, Nagengast FM, Vasen HF, van ‘t Veer P (2002) Meat consumption and meat preparation in relation to colorectal adenomas among sporadic and HNPCC family patients in The Netherlands. Eur J Cancer 38(17):2300–2308PubMedCrossRefGoogle Scholar
  51. 51.
    Botma A, Vasen HF, van Duijnhoven FJ, Kleibeuker JH, Nagengast FM, Kampman E (2013) Dietary patterns and colorectal adenomas in Lynch syndrome: the GEOLynch cohort study. Cancer 119(3):512–521. doi:10.1002/cncr.27726 PubMedCrossRefGoogle Scholar
  52. 52.
    Mathers JC, Movahedi M, Macrae F, Mecklin JP, Moeslein G, Olschwang S, Eccles D, Evans G, Maher ER, Bertario L, Bisgaard ML, Dunlop M, Ho JW, Hodgson S, Lindblom A, Lubinski J, Morrison PJ, Murday V, Ramesar R, Side L, Scott RJ, Thomas HJ, Vasen H, Gerdes AM, Barker G, Crawford G, Elliott F, Pylvanainen K, Wijnen J, Fodde R, Lynch H, Bishop DT, Burn J, Investigators C (2012) Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol 13(12):1242–1249. doi:10.1016/s1470-2045(12)70475-8 PubMedCrossRefGoogle Scholar
  53. 53.
    Burn J, Bishop DT, Mecklin JP, Macrae F, Moslein G, Olschwang S, Bisgaard ML, Ramesar R, Eccles D, Maher ER, Bertario L, Jarvinen HJ, Lindblom A, Evans DG, Lubinski J, Morrison PJ, Ho JW, Vasen HF, Side L, Thomas HJ, Scott RJ, Dunlop M, Barker G, Elliott F, Jass JR, Fodde R, Lynch HT, Mathers JC, Investigators C (2008) Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 359(24):2567–2578. doi:10.1056/NEJMoa0801297 PubMedCrossRefGoogle Scholar
  54. 54.
    Win AK, Dowty JG, Antill YC, English DR, Baron JA, Young JP, Giles GG, Southey MC, Winship I, Lipton L, Parry S, Thibodeau SN, Haile RW, Gallinger S, Le Marchand L, Lindor NM, Newcomb PA, Hopper JL, Jenkins MA (2011) Body mass index in early adulthood and endometrial cancer risk for mismatch repair gene mutation carriers. Obstet Gynecol 117(4):899–905. doi:10.1097/AOG.0b013e3182110ea3 PubMedCrossRefGoogle Scholar
  55. 55.
    Blokhuis MM, Pietersen GE, Goldberg PA, Algar U, Van der Merwe L, Mbatani N, Vorster AA, Ramesar RS (2010) Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters. Fam Cancer 9(3):357–363. doi:10.1007/s10689-010-9334-9 PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Fränzel J. B. van Duijnhoven
    • 1
  • Akke Botma
    • 1
  • Renate Winkels
    • 1
  • Fokko M. Nagengast
    • 2
  • Hans F. A. Vasen
    • 3
  • Ellen Kampman
    • 1
    • 4
    • 5
  1. 1.Division of Human NutritionWageningen UniversityWageningenThe Netherlands
  2. 2.Department of Gastroenterology and HepatologyRadboud University Nijmegen Medical CenterNijmegenThe Netherlands
  3. 3.Netherlands Foundation for the Detection of Hereditary Tumours and Department of Gastroenterology and HepatologyLeiden University Medical CentreLeidenThe Netherlands
  4. 4.Department of Health EvidenceRadboud University Nijmegen Medical CenterNijmegenThe Netherlands
  5. 5.Department of Health SciencesVU University AmsterdamAmsterdamThe Netherlands

Personalised recommendations